Skip to Content

Clinical Trials

Clinical trials are fundamental to the development of innovative medicines and devices that treat and prevent illness. The success of clinical trials depends on the participation of volunteers. Participants in clinical trials gain access to new research treatments not yet available to the public while helping others by contributing to medical research.

If you are a patient looking for information about clinical trials, VIVUS posts information about ongoing clinical trials on a government-mandated web page at www.clinicaltrials.gov, which is a National Institutes of Health registry of ongoing trials that are open and intended for patients with serious or life-threatening diseases. Registration of these trials in this registry is required by law.

Please contact us to learn more about how we work with dedicated and compassionate healthcare providers to identify and advance treatment options that address serious unmet medical needs.

Our Development Pipeline

With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. Our development pipeline is evolving as we advance new compounds through the clinic and to the market.

Tacrolimus, our lead pipeline program, is being developed to treat pulmonary arterial hypertension (PAH). We expect that tacrolimus will be the first in a series of exciting pipeline opportunities. We are identifying and pursuing additional molecules that have preliminary safety and efficacy data that may allow us to reduce our development risk and move more quickly toward the market.

We invite dedicated and compassionate healthcare providers to join our clinical community. Please contact us to learn more about how we work with healthcare providers to identify and advance treatment options that address serious unmet medical needs.

Compound / Product
Phase 1
Phase 2
Phase 3
 
 
 
 
Tacrolimus

Pulmonary Arterial
Hypertension (PAH)

More Information

 
 
 
Phase 2
Phase
1
2
3
 
 
 
 
 
 
Tacrolimus  

Pulmonary Arterial Hypertension (PAH)

More Information

 
 
 
 
 
Phase 2

Other Links & Resources

You are about to leave the VIVUS Inc. website

Links to third-party websites on VIVUS.com are provided solely for your convenience.

VIVUS Inc. does not control the content contained on any third-party website linked from this website. Activities on third-party websites will be governed by the policies and terms of use of those third parties.